Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2009 4
2010 7
2011 4
2012 5
2013 3
2014 1
2015 1
2016 3
2017 2
2018 1
2019 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
A Critical Approach of Guideline Therapeutic Recommendations for NAFLD.
Djordjevic DB, Zdravkovic M, Nagorni A, Manolis A, Tsioufis C, Lovic D. Djordjevic DB, et al. Among authors: nagorni a. Curr Vasc Pharmacol. 2018;16(3):228-238. doi: 10.2174/1570161115666170621080228. Curr Vasc Pharmacol. 2018. PMID: 28676026 Review.
Cameron ulcer.
Djurić Z, Nagorni A. Djurić Z, et al. Among authors: nagorni a. J Pediatr Gastroenterol Nutr. 2013 May;56(5):e29. doi: 10.1097/MPG.0b013e3182504a09. J Pediatr Gastroenterol Nutr. 2013. PMID: 22367337 No abstract available.
Antioxidant supplements for liver diseases.
Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C. Bjelakovic G, et al. Among authors: nagorni a. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007749. doi: 10.1002/14651858.CD007749.pub2. Cochrane Database Syst Rev. 2011. PMID: 21412909 Review.
Faecal occult blood screening for colorectal cancer in Serbia: a pilot study.
Scepanovic M, Jovanovic O, Keber D, Jovanovic I, Miljus D, Nikolic G, Kovacevic B, Pavlovic A, Dugalic P, Nagorni A, Grgov S, Knezevic S, Milenkovic P, Perisic N, Faivre J. Scepanovic M, et al. Among authors: nagorni a. Eur J Cancer Prev. 2017 May;26(3):195-200. doi: 10.1097/CEJ.0000000000000247. Eur J Cancer Prev. 2017. PMID: 27082163
Rapunzel syndrome.
Petrović G, Nagorni A, Bjelaković G, Stojanov DB, Dinić BR, Brzacki V. Petrović G, et al. Among authors: nagorni a. Vojnosanit Pregl. 2012 Aug;69(8):717-20. Vojnosanit Pregl. 2012. PMID: 22924270
[Synchronous colorectal adenomas].
Radovanović-Dinić B, Nagorni A, Stamenković I, Zlatic A. Radovanović-Dinić B, et al. Among authors: nagorni a. Srp Arh Celok Lek. 2010 May-Jun;138(5-6):309-14. doi: 10.2298/sarh1006309r. Srp Arh Celok Lek. 2010. PMID: 20607974 Free article. Serbian.
38 results